Form B - Candidate evidence for VPD
Document ID: 000029-a2 Version: 9.0
Document No.: 000029-a2.10
Approval date: 25/01/2023
Printed copies are uncontrolled and will expire within 24 hours of printing
Brand names of vaccines -below list not
extensive, refer to Australian Immunisation Handbook
7
Measles, Mumps, Rubella
M-M-R-II
Priorix
Priorix-tetra
ProQuad
Pertussis
Adacel/Adacel Polio
Boostrix/Boostrix IPV
Varicella
Varilrix
Varivax
Priorix-tetra
ProQuad
Shingrix
Zostavax
Covid-19 (Refer to
Approved and
recognized COVID-19 vaccinations)
Pfizer – Comirnaty
AstraZeneca – Vaxzevria & Covishield
Moderna - Spikevax
Janssen – COVID-19 Vaccine Janssen
Hepatitis B
H-B-Vax II (adult or paediatric formulation)
Engerix-B (adult or paediatric formulation)
Infanrix hexa
Twinrix/Twinrix Junior
ComVax
Hepatitis A
Avaxim
Havrix/ Havrix Junior
Vaqta
Twinrix/Twinrix Junior
Vivaxim
Footnotes and further information
1.
Positive IgG (Immunoglobulin G) indicates evidence of
serological immunity, which may result from either
natural infection or immunisation.
2.
Pre-offer of employment requires minimum of one
dose of measles, mumps, rubella (MMR) vaccine
course. The prospective worker will be required to
commit to completing the full course. Second dose to
be administered within one month of first dose.
Vaccines given under 12 months of age are not
considered a valid dose
3.
Australian Immunisation Handbook recommends for
occupational groups as healthcare workers to
receive 2 doses of varicella vaccine if they are not
immune. Pre-offer of employment requires minimum
of one dose of varicella (chicken pox) vaccine. The
prospective worker will be required to commit to
completing the full course. Second dose to be
administered within one month of first dose.
4. Anti-HBs (hepatitis B surface antibody) greater than or
equal 10 International units/mL indicates immunity. If
the result is less than 10 International units/mL (<10
IU/mL), this indicates lack of immunity.
5.
Primary Hepatitis B vaccine course is recommended:
- 1
st
dose: day 0 (day of vaccination)
- 2
nd
dose: 1 month after 1
st
dose
- 3
rd
dose: 6 months after 1
st
dose
With minimal intervals between doses:
- 1
st
and 2
nd
dose is 1 month
- 2
nd
and 3
rd
dose is 2 months
- 1
st
and 3
rd
dose is 4 months
For adolescents between the ages of 11-15, adult
hepatitis B vaccine may be given as a two-dose
course, with the two doses 6 months apart.
Accelerated schedules are not accepted.
Pre-offer of employment requires a minimum of two
doses of Hepatitis B at least one month apart. The
prospective worker will be required to commit to
completing the full course. Third dose to be
administered within Hepatitis B vaccine course
recommendations
5
.
Australian Immunisation Handbook recommends for
people at occupational risk, Healthcare workers, to
check level of Anti-HBs (hepatitis B surface antibody)
after the vaccination course. This is to assess for
seroconversion. E.g., Check one month after dose 3.
Further vaccination (up to 6-doses) may be
recommended as per
Australian Immunisation
Handbook if immunity is not obtained post dose 3.
Candidates who are hepatitis B non-responders (after
6 dose vaccination course) can be referred to SCHHS
infectious diseases clinic for intradermal vaccination
review.
6.
Documented evidence that an individual is not
susceptible to hepatitis B infection may include
serology testing indicating a hepatitis B core
antibody (Anti-HBc / HBcAb), or a documented
history of past hepatitis B infection. Prospective
workers (including students and volunteers) who are
hepatitis B antigen positive do not have to disclose
their hepatitis B infection status but must comply
with the
SCHHS Infected Health Care Workers:
Management of Blood Borne Viruses procedure.
7.
Brand names of vaccines not in the Australian
Immunisation Handbook are vaccines that were
included in previous immunisation schedules.
Internationally administered vaccine may have a
different brand name.
8.
Pre-offer of employment/ engagement requires
evidence of completed COVID-19 vaccine course
within recommended schedule.